Efficacy and safety of low-dose steroid treatment in asymptomatic patients with autoimmune pancreatitis. Efficacy and safety of low-dose steroid treatment in asymptomatic patients with autoimmune pancreati ...
Efficacy and safety of low-dose steroid treatment in asymptomatic patients with autoimmune pancreatitis. - Usefulness of low-dose steroid treatment in patients with autoimmune pancreatitis. Efficacy and safety of low-dose steroid treatment in asymptomatic patients with autoimmune pancreati ...
Randomized controlled trial which examines whether resuming steroid can prevent clinical relapse in the patients with asymptomatic high levels of serum IgG after ceasing steroid therapy for autoimmune pancreatitis Randomized controlled trial which examines whether resuming steroid can prevent clinical relapse in ...
Randomized controlled trial which examines whether resuming steroid can prevent clinical relapse in the patients with asymptomatic high levels of serum IgG after ceasing steroid therapy for autoimmune pancreatitis - Steroid resuming study after serological relapse in AIP Randomized controlled trial which examines whether resuming steroid can prevent clinical relapse in ...
autoimmune pancreatitis
Prednisolone at a dose of 10mg/day is started. The dose is taperd by 2.5mg every 8-10 weeks until reaching 5mg/day. Maintenance therapy at a dose of 5 mg/day is continued. Resuming or increasing prednisolone is not planned. Patients during the course of tapering prednisolone continue to taper the dose until its complete cessation. Prednisoloneat a dose of 10mg/day is started. The dose is taperd by 2.5mg every 8-10 weeks until rea ...
Department of Gastroenterology, University of Tokyo